Rate My Professor Nicholas Collins

Collins's research focuses on congenital heart disease, pulmonary hypertension, peri-operative cardiology assessment, and interventional cardiology. His scholarly output includes over 190 publications and more than 2,300 citations, reflecting substantial influence in the field. Notable works encompass the "Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial" published in Circulation (2020), "Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes" in The Lancet Diabetes & Endocrinology (2019), "Pulmonary hypertension due to left heart disease: diagnosis, pathophysiology, and therapy" in Hypertension (2020), "Diagnostic delay in pulmonary arterial hypertension: insights from the Australian and New Zealand pulmonary hypertension registry" in Respirology (2020), and "Pseudoaneurysm after transradial cardiac catheterization: case series and review of the literature" in Catheterization and Cardiovascular Interventions (2012). Recent contributions include leadership in trials such as the EAGER randomised controlled trial on guidewire efficacy for transradial access (2024) and the SCOFF trial on no fasting prior to catheterization procedures (2024). His work advances understanding and management of acute coronary syndromes, procedural safety, and pulmonary vascular diseases.